INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Operating Lease, Payments in USD from Q2 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Operating Lease, Payments history and growth rate from Q2 2019 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Operating Lease, Payments for the quarter ending September 30, 2023 was $73K, a 31.1% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. Operating Lease, Payments for the twelve months ending September 30, 2023 was $400K, a 5.88% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2022 was $427K, a 5.96% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2021 was $403K, a 7.47% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2020 was $375K, a 54.3% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $400K $73K -$33K -31.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $433K $109K +$3K +2.83% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $430K $109K +$3K +2.83% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $427K $109K +$2K +1.87% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $425K $106K +$3K +2.91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $422K $106K +$8K +8.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $414K $106K +$11K +11.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $403K $107K +$11K +11.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $392K $103K +$10K +10.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $382K $98K +$5K +5.38% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $377K $95K +$2K +2.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $375K $96K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $93K +$3K +3.33% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $93K +$33K +55% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $93K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $90K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $60K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.